USPTO serial 79371135
AXXINOVAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 30, 2024
- Examiner
- SOUDERS, MICHAEL J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AXXINOVAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Louis J. Levy
Louis J. Levy Symbus Law Group PLLC1775 I Street, NW, Suite 1150Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations | ACTIVE | — |
| 035 | Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others | ACTIVE | — |
| 042 | Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological diseases, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematological conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Jitesh Devendra
- Other trademarks owned by Jitesh Devendra
- Other trademarks owned by Jitesh Devendra
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named AXXINOVAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2024 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 1, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 24, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 24, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 17, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 17, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 16, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |